Provides flexibility in drug development, clinical trials and lifecycle management.
FlexibleAccommodates both 1mL and 2.25mL glass syringes in the same
device and readily adapts to different fill volumes with no changed parts.
Reduces complexity and risk in supply chain, and final assembly
Simple effective branding and customisation options.
Owen Mumford Pharmaceutical Services have a proven track record and broad
experience of auto-injector development, manufacture and supply
Drug Development and Lifecycle Management
Aidaptus® is especially suitable for reducing risk during drug development and
lifecycle management, if the drug formulation has to change - this device doesn’t.
Independent 2 phase needle insertion and drug delivery, limiting
impact forces on the syringe, which reduces risk of syringe breakages
Fast to Market
Minimal change parts for platform capability, which reduces risk.
2-step use, automatic needle insertion, simple steps for use.
If you would like to find out more
Enter your details below
The customiser tool for Aidaptus® will open on a new tab.
Are you happy to continue?
The About us page will open on a new tab.